Sharps Technology Inc. STSS shares are trading higher Thursday after the company signed a $30 million purchase order from Nephron Pharmaceuticals. Sharps said the purchase order represents the first ...

Sharps Technology Inc (NASDAQ:STSS) shares are trading higher by 39.8% to $0.63 during Thursday’s session after the company signed a 5-year $200 million syringe sales agreement with Nephron ...

Sharps Technology Inc. Annual cash flow by MarketWatch. View STSS net cash flow, operating cash flow, operating expenses and cash dividends.

NEW YORK, Oct. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ: STSS) today announced a stock repurchase program to acquire up to $100 million of the company's ...

Director Danner Paul K. recently purchased 5 shares of Series B Preferred Stock of Sharps Technology Inc. (NASDAQ: STSS) at a price of $20.00 per share. The total value of this transaction, which ...

Medical device and pharmaceutical packaging company Sharps Technology (NASDAQ:STSS) said on Monday that it will effect a 1-for-22 reverse stock split, effective Oct. 15 11:59 PM ET. STSS shares were ...

Dividend history information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending. Nasdaq Data provided by Nasdaq ...

Medical device company Sharps Technology (NASDAQ:STSS) is enjoying a massive surge in its share price today following the close of its initial public offering (IPO). STSS stock is up more than 40% ...

Sharps Technology (NASDAQ:STSS) stock is up on Thursday after the medical device company announced a $30 million purchase order for its specialty copolymer prefillable syringes. Sharps Technology says ...